S100B and COVID-19: Furthermore, among individuals admitted to an intensive care unit (ICU) for COVID-19, serum S100B levels were elevated in non-survivors compared to survivors, showing a notable correlation with inflammatory markers, such as lymphocyte counts and interleukin-6 (IL-6) levels [75].